All lobbying filings

VANTIVE US HEALTHCARE LLC

Lobbying for VANTIVE US HEALTHCARE LLC · Medical Technology Manufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $450,000.00 expenses · posted Jul 21, 2025

Official filing document

Bills named in this filing 1

HR 4441
Patient Access to Innovative New Technologies Act of 2025

Lobbying activity 4

Medicare/Medicaid

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act

Health Issues

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring

Foreign Relations

Issues related to resolving outstanding legal claims

Trade (domestic/foreign)

Issues related to tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.